glp 1 and naion Sight Unseen: Glucagon-Like Peptide-1 (GLP-1) Agonism Therapy Nonarteritic Anterior Ischemic Optic Neuropathy Ophthalmic Complications Observed After Use

GLP-1 Patent Expiry: The Next Big Pharma Race Has Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have reshaped the global diabetes and obesity market

PBM pricing

Hims & Hers announced a $250 million share buyback program, but escalating GLP-1 price competition from Novo Nordisk overshadowed the news

Glucagon-like peptide-1 (GLP-1) receptor is widely distributed in the digestive system, cardiovascular system, adipose tissue and central nervous system

Semaglutide the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy

The new savings options (including 3, 6, and 12 month prepaid plans) enable cash paying patients to access new, lower prices available for both the Wegovy pen or pill